ScholarLens Back to search
2014•Journal watchRequires access

Combining Basal Insulin and GLP-1 Agonists Is Effective in Advanced Type 2 Diabetes

Bruce Soloway

Open publisher page 0 citations

Abstract

Recent studies have suggested that combining basal insulin and glucagon-like peptide-1 (GLP-1) agonists (e.g., exenatide) might be particularly useful

About this research paper

What this paper is about

Recent studies have suggested that combining basal insulin and glucagon-like peptide-1 (GLP-1) agonists (e.g., exenatide) might be particularly useful

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Recent studies have suggested that combining basal insulin and glucagon-like peptide-1 (GLP-1) agonists (e.g., exenatide) might be particularly useful

Key concepts: Basal insulin, Type 2 diabetes, Medicine, Insulin, Basal (medicine), Diabetes mellitus, Internal medicine, Endocrinology

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Combining Basal Insulin and GLP-1 Agonists Is Effective in Advanced Type 2 Diabetes — Research Paper | ScholarLens